WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000058502) USE OF COLLAGENASE 3 FOR DETECTING DESTRUCTIVE DISEASES OF THE JOINTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/058502    International Application No.:    PCT/DE2000/000881
Publication Date: 05.10.2000 International Filing Date: 24.03.2000
Chapter 2 Demand Filed:    19.10.2000    
IPC:
C12Q 1/37 (2006.01), G01N 33/564 (2006.01), G01N 33/573 (2006.01)
Applicants: MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN [DE/DE]; Robert-Rössle-Strasse 10, D-13125 Berlin (DE) (For All Designated States Except US).
WERNICKE, Dirk [DE/DE]; (DE) (For US Only).
GROMNICA-IHLE, Erika [DE/DE]; (DE) (For US Only).
FREUDIGER, Dirk [DE/DE]; (DE) (For US Only).
SCHULZE WESTHOFF, Claudia [DE/DE]; (DE) (For US Only)
Inventors: WERNICKE, Dirk; (DE).
GROMNICA-IHLE, Erika; (DE).
FREUDIGER, Dirk; (DE).
SCHULZE WESTHOFF, Claudia; (DE)
Agent: BAUMBACH, Fritz; Robert-Rössle-Strasse 10, D-13125 Berlin (DE)
Priority Data:
199 13 428.6 25.03.1999 DE
Title (DE) VERWENDUNG VON KOLLAGENASE 3 ZUM NACHWEIS VON DESTRUKTIVEN GELENKERKRANKUNGEN
(EN) USE OF COLLAGENASE 3 FOR DETECTING DESTRUCTIVE DISEASES OF THE JOINTS
(FR) UTILISATION DE COLLAGENASE 3 POUR IDENTIFIER LES MALADIES DE DESTRUCTION ARTICULAIRE, EN PARTICULIER POUR PREVOIR L'EVOLUTION DE LA MALADIE ET POUR DETERMINER LES PREDISPOSITIONS GENETIQUES A L'ARTHRITE RHUMATOIDE (RA)
Abstract: front page image
(DE)Die Erfindung betrifft die Verwendung von Kollagenase 3 zum Nachweis von destruktiven Gelenkerkrankungen, insbsesondere zur Prognose des Krankheitsverlaufs und zur genetischen Prädisposition der Rheumatoiden Arthritis (RA).
(EN)The invention relates to the use of collagenase 3 for detecting destructive diseases of the joints, especially for prognosing the progression of the disease and the genetic predisposition for rheumatoid arthritis.
(FR)L'invention concerne l'utilisation de collagénase 3 pour identifier les maladies de destruction articulaire, en particulier pour prévoir l'évolution de la maladie et pour déterminer les prédispositions génétiques à l'arthrite rhumatoïde (RA).
Designated States: JP, US.
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM).
Publication Language: German (DE)
Filing Language: German (DE)